The Abacavir 60mg Dispersible Tablets – PAC-60 are effective antiretroviral tablets designed to treat pediatric HIV infections. These tablets contain 60mg of Abacavir Sulfate, renowned for its superior efficiency in treating HIV. The product comes in a pack of 60 tablets, enclosed in a sealed container with a safety Warning Card. Please keep it stored below 30u00b0C (86u00b0F) to retain its top-quality. The tablets enjoy a substantial shelf life of 24 months and align with WHO treatment guidelines and the WHO Prequalified Medicines catalog, attesting to their safety and reliability.
Meet Abacavir 60mg Dispersible Tablets - PAC-60, a breakthrough antiretroviral treatment specifically designed for pediatric HIV therapy. It contains the potent active agent Abacavir, a widely recognized nucleoside reverse transcriptase inhibitor (NRTI) that inhibits HIV replication and enhances immune response in children. This bioengineered antiretroviral therapy offers hope in the global fight against HIV/AIDS.
Abacavir 60mg Dispersible Tablets are prescribed for managing HIV infection in children. They are advised to be taken alongside at least two other antiretroviral drugs for best results. For specific usage instructions, refer to authoritative resources such as the WHO treatment guidelines, WHO Essential Medicines Library, or regional/national guidelines.
Keep the medication in its original container and tightly sealed for best preservation. Avoid repackaging. Store the drug in a place inaccessible to children, and do not exceed the maximum storage temperature limit of 30u00b0C.
Stay updated on the regulatory status via the List of WHO Prequalified Medicines or the list of items approved (and tentatively approved) by the USFDA.